Trade Summary

Yesterday, Booth Bruce, serving as Dir at Kymera Therapeutics, Inc. (KYMR), sold 285,684 shares at $121.86 per share, for a total transaction value of $34,812,908.93. Following this transaction, Booth Bruce now holds 529,718 shares of KYMR.

This sale represents a 35.04% decrease in Booth Bruce's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 25, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 26, 2026 (accepted Jun 25, 9:56 PM ET), 1 day after the trade was made.

Kymera Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.